PKS VIDEO LIBRARY
<< View complete library >>
NEWS from CONSORTIUM MEMBERS
For the fourth year in a row, Stephen K. Klasko, MD, MBA, has been named one of the most influential clinical executives by Modern Healthcare.This list honors those in the healthcare industry who are deemed by their peers to demonstrate exceptional leadership qualities in the field, including executive responsibility, innovation, community service and various achievements.
<<FULL STORY>>
Women carrying twins are at higher risk for premature birth and miscarriage – those whose cervix dilates before 24 weeks are at highest risk – and yet one common treatment is not recommended for this population. A new multi-center randomized-controlled trial from Thomas Jefferson University shows that cerclage, an intervention that sutures a dilating cervix closed, can help prevent preterm birth and miscarriage. The findings could overturn existing guidelines.
The National Institutes of Health (NIH) announced today that researchers from Children’s Hospital of Philadelphia (CHOP) are among the recipients of a multi-million dollar grant that focuses on the use of genomics to improve risk assessment for diverse populations and integrate the findings into clinical care.
A CHOP allergy specialist recently presented on how to choose the right treatment for eosinophilic esophagitis (EoE) at the EAACI Annual Congress 2020. The international conference for health professionals was held digitally this year on June 6-8 due to the COVID-19 pandemic.
Since the COVID-19 pandemic began, fewer children than usual have visited emergency rooms. But doctors across the country say they have seen a growing number of children who suffered broken bones on bikes and trampolines, accidental poisonings, and other severe injuries during the widespread lockdowns. In fact, recent research conducted by experts at Children’s Hospital of Philadelphia (CHOP) published in the Journal of Pediatric Orthopaedics suggests a need for increased awareness of at-home safety measures.
The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, announces the appointment of Chengyu Liang, M.D., Ph.D., as professor in the Molecular & Cellular Oncogenesis Program of The Wistar Institute Cancer Center.
<<FULL TEXT>>
The effects of COVID-19 have dramatically changed the way we live, learn and work. While many things have come to a standstill, Wistar research has never stopped and even new educational projects have managed to come to fruition. One shining addition to the Institute this summer is the newly constructed, state-of-the-art educational biomedical training suite.
Despite an unprecedented volume of research, there are still many unanswered questions on COVID-19, especially regarding the extremely varied clinical course the disease takes, ranging from asymptomatic to severe, even fatal. The evidence collected so far points to the so called “cytokine storm” as a major factor determining the final outcome.
The Wistar Institute, a biomedical research leader in cancer, immunology and infectious diseases, and Allevi, Inc. a Philadelphia based startup pioneering innovative 3D biofabrication technologies, announce a collaboration to use 3D bioprinting to help combat COVID-19.
Jefferson Health has named Brian Sweeney as president and chief operating officer of its New Jersey division. Sweeney, a 23-year Jefferson Health veteran, began his career as a registered nurse. He had been serving as interim president since early March when he took over the job previously held Joseph D. Devine.
Sponsors
If you want to stay informed about BioStrategy Parterns, subscribe here.
SUBSCRIBE
bryan.tsao@biostrategypartners.org 785-656-0891
Copyright 2017, BioStrategy Partners. All rights reserved
